Copy
Health Enterprise Partners 

In this
issue...

  Portfolio Update
  Q&A with Zack King
  White Paper: Beyond Meaningful Use: Harnessing Data’s Potential in the Post-Reform Era Executive Perspectives by Ezra Mehlman
  News from HEP Team

Portfolio Update

AllyAlign Health
HEP co-led a financing of AllyAlign Health.  AllyAlign’s goals are two-fold: to improve the care of patients with chronic and complex medical conditions and to improve the profitability of long-term care providers.  AllyAlign primarily utilizes care teams and technology to improve outcomes, decrease costs and thrive in a changing managed care environment.  AllyAlign engages with payers in quality-based contracts that recognize and reward out-of-the-box care delivery options for medically complex patients. Read More

eVariant
The company launched a new website focused on an effort to improve the user experience, streamline product and service information and provide a channel for better communication and interaction with clients. Read More.

Nordic
The 2013 Best in KLAS report published last week ranked Nordic 2nd in the Implementation Supportive Clinical category.  The company also received the highest KLAS Konfidence rating of the top 4 firms in the category and increased its overall score year over year by 5 percentage points to 93.3%.  In the last year, the company launched 3 new lines – affiliate, optimization, and remote solutions.  76 Nordic consultants are working with 13 clients across these service lines currently.  Read More.

Privia
Privia Medical Group was formed at the end of 2013 with 143 doctors who had been using Privia's care-support software. The new group, with offices in northern Virginia, D.C. and Montgomery County, Maryland, will share a single tax identification number and brand, as well as a contract with insurers as a single entity.  Read More.

SCIO Health Analytics
SCIO ranked 173 Among Fastest Growing Companies in North America by Deloitte’s 2013 Technology Fast 500™. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2008 to 2012.  Read More.

Trinity
HEP invested $15M of growth capital with Trinity Pharma, a provider of cloud-based data, analytics and mobile solutions for the global life sciences industry. The investment will enable Trinity to extend its solutions in response to strong demand for cloud-based, big data healthcare analytics.  Read More.

Q&A

Q&A with Zack King

Zack King, co-founder and CEO of Trinity Pharma, gave us insight on challenges and trends in the pharma industry, Trinity’s company culture and a look into life outside the office. Read Zack’s full bio here.

How do you see innovations in big data changing the dynamics of the pharma industry?
Pharma is entering an era where data will be the primary driver for most of its sales and marketing decisions, tactics, and strategy. Historically, life science companies relied heavily on pure science and patents as the underpinnings of brand success. With fewer blockbusters, big data will allow pharma to be smarter about the way it approaches its customers through deeper analysis and predictive modeling of prescribing behavior. Big data will also play a huge role in the evolving commercial and business model changes (Commercial 3.0) whereby brand performance is measured more on healthy outcomes rather than the number of prescriptions written. A confluence of factors will center on leveraging big data to drive change including consumerism, healthcare reform, health IT and value mining.
 
How has the culture within Trinity evolved since you founded the company in 2002?
I’ll first start by saying what hasn’t changed and that’s a relentless focus on customer value and service. We’re a technology company but real people whose jobs are on the line rely on us every day and we never lose sight of that. What has changed is a shift in our culture to enable a more innovative and dynamic workforce with a focus on freedom. Today’s knowledge worker is different and we continually enhance and evolve our culture to reflect a more positive, group-oriented, can-do ethos. We moved offices to a location that was a better fit with our culture (think loft, bricks, open floor plan and water views) that offers a more collaborative and creative space for team. We keep it fun with a company shuffle board and regular team building off-sites.
 
What are the greatest challenges affecting pharmaceutical companies in the current environment?
The biggest challenges in pharma right now are the prospect of fewer blockbuster products and the shift in commercial models with health outcomes as the new currency going forward. We’re focused on both opportunities. First by helping pharma drive more value from the products they market through better analytics. Specialized (non-blockbuster) products require sophisticated analytics to understand the customer and how best to engage them. Second – the Affordable Care Act will change the way pharma (and many other in the health ecosystem) measure success. Many of these changes involve new uses and sources of information that is forming the basis for a new class of analytics focused on health outcomes.
 
What is the most valuable marketing trend that pharma companies should be latching onto right now?
There’s a lot of talk about sales forces being cut, but the data shoes that quality, face-to-face interaction with reps remains an essential element to brands success. Still more than 50% of US pharma marketing spend is in detailing. Traditional marketing spend is not declining but is shifting and the channel mix has evolved dramatically over the past 10 years. The emerging trend is in what is called multi-channel marketing which simply means finding the right mix of face-to-face, phone, payor, digital and other means to influence and engage a customer (doctor, patient, etc.). We’re seeing more opportunities for our platform since these new channels are creating new sources of data (e.g. social media), new types of analytics (e.g. channel optimization), and a whole new level of detail needed to target and understand the customer.
 
What occupies your time outside the office?
My two kids (8 and 4) occupy quite a bit! Personally I try and lead an active lifestyle and I sail competitively in the summer which is part of the reason we live in Bristol, RI. In the winter we spend as many weekends on the mountains in Vermont skiing and snowboard as we’re able. I’m a mentor to tech startups in and around RI which is a rewarding way to give back to the business community, hopefully spur some economic development and sharpen my own skills by surround myself with smart and energetic entrepreneurs.
 

White Paper

Beyond Meaningful Use: Harnessing Data’s Potential in the Post-Reform Era Executive Perspectives by Ezra Mehlman

Last quarter, Ezra Mehlman hosted the 2nd annual HEP Survey and Webinar in conjunction with Avalere Health. The survey was entitled “Harnessing Data's Potential in the Post-Reform Era” and was distributed to over 2,000 hospital system and integrated delivery network (IDN) administrators, health plan executives, and health care companies. The key findings of the survey were presented in a webinar which featured a discussion with Dr. William Morris, Associate Chief Medical Information Officer of the Cleveland Clinic, Dan Mendelson, the Founder and CEO of Avalere Health, and Anne Tumlinson, SVP of Avalere Health.

Find the entirety of the White Paper here.

News From HEP Team

  • David Tamburri was the moderator on a panel entitled “Healthcare Entrepreneurship and Venture Panel” at the Columbia Business School Healthcare Conference this past November. The panel included: Tamara Elias MD, Partner, Essex Woodlands Health Ventures; Bill Goldberg, Chief Executive Officer, MediMedia; Mitch Rothschild, Chief Executive Officer, Vitals; and Andrew Schiff, MD, Managing Partner, Aisling Capital.
  • David was also a panelist at the Connecticut Venture Group Healthcare IT event hosted at Rensselaer Polytechnic Institute’s Hartford campus titled, “The Power of Big Data and Analytics Tools Evolution and Opportunity in Healthcare IT”. He was joined by Eric Rosow, President of Scry Health and Andy Brooks, VP Operations and Finance with HealthFleet.
  • Dan Cain will participate as a speaker during a panel discussion at Becker’s Hospital Review Annual Meeting in Chicago on May 16th on “Key Issues in Hospital and Health System Consolidation and Affiliation”.
Copyright © 2014 Health Enterprise Partners, All rights reserved.
Email Marketing Powered by Mailchimp